Hematologic, hemostatic, and biochemical effects in cats receiving an oral chondroprotective agent for 30 days.

Veterinary therapeutics : research in applied veterinary medicine

Volumn 1, Issue 2, 2000, Pages 108-117

  McNamara, P S ^a   Barr, S C ^a   Erb, H N ^a   Barlow, L L ^a  

^a Capital District Veterinary Surgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A73025; CHONDROITIN SULFATE; ELECTROLYTE; ENZYME; GLYCOSAMINOGLYCAN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CELL COUNT; CAT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD CELL COUNT; CATS; CHONDROITIN SULFATES; ELECTROLYTES; ENZYMES; FEMALE; GLYCOSAMINOGLYCANS; PLATELET AGGREGATION; PROTHROMBIN TIME;

EID: 0038355694     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)